NEU neuren pharmaceuticals limited

Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m, page-33

  1. 18,374 Posts.
    lightbulb Created with Sketch. 5232
    I see it as being the opposite, all the replies result in NEU constantly being one of the top discussed stocks which brings new investors to this forum (and therefore to NEU). Sunny, inadvertently, is actually attracting people who were likely unaware about NEU to these forums, where they have the opportunity to view some of the fantastic analysis that is posted here.

    Anyone with even a pinch of intelligence can see past Sunny's dribble, meaning that the only affect of his insistent posting is that more new investors are attracted to NEU forum, giving them the opportunity to see for themselves how undervalued this company is. I doubt anyone actually listens to what this poster has to say though...

    He's basically having the opposite of the intended effect of downramping, and any replies to his posting only serve to increase awareness of this gem
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.000(0.00%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.61 $12.68 $12.32 $7.219M 577.9K

Buyers (Bids)

No. Vol. Price($)
1 2968 $12.51
 

Sellers (Offers)

Price($) Vol. No.
$12.57 540 1
View Market Depth
Last trade - 16.16pm 25/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.